← All indications
Radiodermatitis
A cutaneous inflammatory reaction occurring as a result of exposure to ionizing radiation.
Drugs by status
Phase 4 trials (3)
Phase 3 trials (12)
Phase 2 trials (17)
Phase 1 trials (2)
Organizations
Organization Involved with Phase 4 Indications (2)
Organization Involved with Phase 3 Indications (13)
- National Cancer Institute (NCI)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- University of Washington
- Institut de Cancérologie de la Loire (ICLN)
- Marilia Medicine School
- North Central Cancer Treatment Group
- Stanford University
- University of Rochester
- University of Brasilia
- Mayo Clinic
- Spartanburg Regional Medical Center
- Yeshiva University
- Institut de Cancérologie Lucien Neuwirth
Organization Involved with Phase 2 Indications (22)
- AbbVie
- Aperion Biologics
- Joben Bio-Medical Co., Ltd.
- ProCertus BioPharm, Inc
- ProTechSure Scientific, Inc.
- Reata Pharmaceuticals, Inc.
- Kaohsiung Medical University
- National Yang-Ming University
- Poudre Valley Health System
- University of South Florida
- Tel Aviv University
- University of Copenhagen
- Shandong University
- Taipei Veteran General hospital
- Isfahan Milad Hospital
- Iran University of Medical Sciences
- Isfahan University
- Sun Yat-Sen University
- University of Colorado
- Efficient Pharma
- China Medical University
- Lutris Pharma Ltd.
Organization Involved with Phase 1 Indications (4)
Organization Involved with Other Experimental Indications (5)